We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Protagen Announces CE Mark for its Proprietary Multilisa® BICD2 Test

News   Jun 16, 2016

 
Protagen Announces CE Mark for its Proprietary Multilisa® BICD2 Test
 
 
 

RELATED ARTICLES

Obesity Linked to Increased Risk of Early-Onset Colorectal Cancer

News

Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University School of Medicine in St. Louis.

READ MORE

How to Define Spectrums of Biomarker Outcomes

News

Defining the full spectrum of human disease associated with a biomarker is necessary to advance the biomarker into clinical practice.

READ MORE

3-in-1 Vaccine Against Traveller’s Diarrhea

News

Conjugate vaccines could be a platform for a multi-pathogen, multi-serotype vaccine against the three major causes of diarrheal disease worldwide.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE